Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Amato

Showing results (81-90 of 295) with videos related to

Pageof 30
Sort By:
Stroke|November 1, 1986
Post-stroke depression: relationships to functional impairment, coping strategies, and rehabilitation outcomeD Sinyor, P Amato, D G Kaloupek, et al.
American Journal of Respiratory and Critical Care Medicine|April 24, 2024
Reply to Chi <i>et al.</i>: Ventilator Waveforms May Give Clues to Expiratory Muscle ActivityGlauco M Plens, Eduardo L V Costa, Giacomo Bellani, et al.
Journal of Neurology|May 7, 2013
Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patientE Piscolla, B Hakiki, L Pastò, et al.
Archives of Neurology|February 1, 1995
Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-upM P Amato, G Ponziani, G Pracucci, et al.
Letters in Applied Microbiology|July 28, 2006
First isolation and characterization of a bacterial strain that biotransforms the herbicide mesotrioneS Durand, P Amato, M Sancelme, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 29, 2001
Quality of life in multiple sclerosis: the impact of depression, fatigue and disabilityM P Amato, G Ponziani, F Rossi, et al.
The Science of the Total Environment|March 22, 2017
Assessment and risk modeling of airborne enteric viruses emitted from wastewater reused for irrigationD Courault, I Albert, S Perelle, et al.
Journal of the Neurological Sciences|July 21, 2004
A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLINF Patti, M P Amato, M Filippi, et al.
Respiratory Care|July 19, 2018
Airway Clearance With an Optimized Mechanical Insufflation-Exsufflation ManeuverMarcia S Volpe, Juliane M Naves, Gabriel G Ribeiro, et al.
Journal of Autoimmunity|October 1, 1990
The influence of high dose intravenous immunoglobulins on immunological and metabolic pattern in newly diagnosed type I diabetic patientsF Pantŏ, C Giordano, M P Amato, et al.
Pageof 30

Showing results (81-90 of 295) with videos related to

Sort By:
Pageof 30
Stroke|November 1, 1986
Post-stroke depression: relationships to functional impairment, coping strategies, and rehabilitation outcomeD Sinyor, P Amato, D G Kaloupek, et al.
American Journal of Respiratory and Critical Care Medicine|April 24, 2024
Reply to Chi <i>et al.</i>: Ventilator Waveforms May Give Clues to Expiratory Muscle ActivityGlauco M Plens, Eduardo L V Costa, Giacomo Bellani, et al.
Journal of Neurology|May 7, 2013
Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patientE Piscolla, B Hakiki, L Pastò, et al.
Archives of Neurology|February 1, 1995
Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-upM P Amato, G Ponziani, G Pracucci, et al.
Letters in Applied Microbiology|July 28, 2006
First isolation and characterization of a bacterial strain that biotransforms the herbicide mesotrioneS Durand, P Amato, M Sancelme, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 29, 2001
Quality of life in multiple sclerosis: the impact of depression, fatigue and disabilityM P Amato, G Ponziani, F Rossi, et al.
The Science of the Total Environment|March 22, 2017
Assessment and risk modeling of airborne enteric viruses emitted from wastewater reused for irrigationD Courault, I Albert, S Perelle, et al.
Journal of the Neurological Sciences|July 21, 2004
A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLINF Patti, M P Amato, M Filippi, et al.
Respiratory Care|July 19, 2018
Airway Clearance With an Optimized Mechanical Insufflation-Exsufflation ManeuverMarcia S Volpe, Juliane M Naves, Gabriel G Ribeiro, et al.
Journal of Autoimmunity|October 1, 1990
The influence of high dose intravenous immunoglobulins on immunological and metabolic pattern in newly diagnosed type I diabetic patientsF Pantŏ, C Giordano, M P Amato, et al.
Pageof 30